We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

30 hedge funds and large institutions have $7.44M invested in TriSalus Life Sciences Warrant in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

15% more funds holding

Funds holding: 26 → 30 (+4)

8% less capital invested

Capital invested by funds: $8.05M → $7.44M (-$608K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
30
Holders Change
+4
Holders Change %
+15.38%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
1
Reduced
2
Closed
3
Calls
$471K
Puts
–
Net Calls
+$471K
Net Calls Change
-$462K

Top Buyers

1
CS
Clear Street
New York
+$46.3K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$21.9K
3
ZCA
Zeke Capital Advisors
Pennsylvania
+$12.7K
4
CM
CastleKnight Management
New York
+$8.87K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.47K

Top Sellers

1
QGA
Q Global Advisors
Texas
-$13K
2
MA
MYDA Advisors
New York
-$11K
3
MF
Magnetar Financial
Illinois
-$3.09K
4
Jane Street
Jane Street
New York
-$40
Name Holding Trade Value Shares
Change 		Change in
Stake
OCAM
26
Owl Creek Asset Management
New York
$1K – – –
OMC
27
Old Mission Capital
Illinois
$1K +$2.04K +10,665 New
MC
28
Meteora Capital
Florida
$1K +$3.27K +17,094 New
MF
29
Magnetar Financial
Illinois
$103 -$3.09K -16,173 -1%
SCC
30
Spring Creek Capital
Kansas
– -$42K -167,566 Closed
QGA
31
Q Global Advisors
Texas
– -$13K -49,561 Closed
MA
32
MYDA Advisors
New York
– -$11K -42,949 Closed
1
2

TLSIW Hedge Fund Activity: Q2 2022 in Review

30 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q2 2022, worth a combined $7.44M — down 7.6% from $8.05M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TLSIW positions and 3 closed out — a net gain of 4 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $46.3K. The largest seller was Q Global Advisors, exiting entirely with an estimated $13K sold.

  • 30 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q2 2022, up from 26 in Q1 2022.
  • Funds reported $7.44M of TriSalus Life Sciences Warrant stock for Q2 2022, down 7.6% quarter-over-quarter.
  • 7 funds opened new TriSalus Life Sciences Warrant positions in Q2 2022 and 3 closed out, a net change of +4 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q2 2022 was Clear Street, an estimated $46.3K added.
  • The largest TriSalus Life Sciences Warrant seller in Q2 2022 was Q Global Advisors, an estimated $13K sold.

Based on aggregated 13F filings for Q2 2022.